NEOGENOMICS INC (NEO) Stock Balance Sheet
NASDAQ:NEO - US64049M2098 - Common Stock
8.78 USD
+1.57 (+21.78%)
8.8 USD
+0.02 (+0.23%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 154.72M | 367.01M | 342.49M | 263.20M | 316.80M | |||
| Marketable Securities | 8.96M | 19.83M | 72.72M | 174.80M | 198.60M | |||
| Receivables | 153.13M | 150.64M | 131.26M | 121.60M | 113.90M | |||
| Inventories | 34.17M | 26.75M | 24.16M | 24.30M | 23.40M | |||
| Other Current Assets | 41.57M | 31.79M | 26.19M | 21.40M | 28.90M | |||
| Total Current Assets | 392.55M | 596.02M | 596.81M | 605.30M | 681.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 168.33M | 173.69M | 183.78M | 198.60M | 211.70M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | 0.00 | |||
| Goodwill | 524.14M | 522.77M | 522.77M | 522.80M | 527.10M | |||
| Intangibles | 301.80M | 339.68M | 373.13M | 408.30M | 442.30M | |||
| Other Non-Current Assets | 7.13M | 5.89M | 4.74M | 5.10M | 6.90M | |||
| Total Non-Current Assets | 1.00B | 1.04B | 1.08B | 1.13B | 1.19B | |||
| TOTAL ASSETS | 1.39B | 1.64B | 1.68B | 1.74B | 1.87B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 200.78M | 0.00 | 100.00K | 1.10M | |||
| Accrued Expenses | 71.09M | 78.45M | 73.84M | 61.80M | 63.00M | |||
| Accounts Payable | 27.49M | 21.61M | 20.33M | 20.50M | 17.90M | |||
| Other Current Liabilities | 1.54M | 409.00K | 2.13M | 7.60M | 5.20M | |||
| Total Current Liabilities | 100.12M | 301.24M | 96.30M | 89.90M | 87.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 341.10M | 340.33M | 538.20M | 535.30M | 532.60M | |||
| Deferred Taxes/Income | 19.98M | 21.51M | 24.29M | 34.80M | 55.50M | |||
| Other Non-Current Liabilities | 78.72M | 72.61M | 80.91M | 82.00M | 86.20M | |||
| Total Non-Current Liabilities | 439.79M | 434.46M | 643.39M | 652.10M | 674.30M | |||
| TOTAL LIABILITIES | 539.91M | 735.70M | 739.69M | 742.00M | 761.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -396.80M | -325.78M | -247.06M | -159.10M | -14.80M | |||
| Additional Paid In Capital | 1.25B | 1.23B | 1.19B | 1.16B | 1.12B | |||
| Common Shares | 128.00K | 128.00K | 127.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | 29.00K | -206.00K | -1.67M | -3.90M | -600.00K | |||
| Shares Outstanding | 128.68M | 128.15M | 127.37M | 126.90M | 124.10M | |||
| Tangible Book Value per Share | 0.22 | 0.31 | 0.36 | 0.53 | 1.12 | |||
| Total Shareholders' Equity | 854.04M | 902.34M | 941.54M | 998.00M | 1.11B | |||
| TOTAL LIABILITIES AND EQUITY | 1.39B | 1.64B | 1.68B | 1.74B | 1.87B | |||
| Statistics | ||||||||
| Debt/Equity | 0.40 | 0.38 | 0.57 | 0.54 | 0.48 | |||
| Current Ratio | 3.92 | 1.98 | 6.20 | 6.73 | 7.82 | |||
| Return On Assets (ROA) | -7.46% | -4.81% | -5.23% | -8.29% | -0.44% | |||
| Return On Equity (ROE) | -12.18% | -8.72% | -9.34% | -14.46% | -0.75% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21